283 related articles for article (PubMed ID: 15105135)
1. Membrane sphingolipid-ergosterol interactions are important determinants of multidrug resistance in Candida albicans.
Mukhopadhyay K; Prasad T; Saini P; Pucadyil TJ; Chattopadhyay A; Prasad R
Antimicrob Agents Chemother; 2004 May; 48(5):1778-87. PubMed ID: 15105135
[TBL] [Abstract][Full Text] [Related]
2. Functional analysis of CaIPT1, a sphingolipid biosynthetic gene involved in multidrug resistance and morphogenesis of Candida albicans.
Prasad T; Saini P; Gaur NA; Vishwakarma RA; Khan LA; Haq QM; Prasad R
Antimicrob Agents Chemother; 2005 Aug; 49(8):3442-52. PubMed ID: 16048959
[TBL] [Abstract][Full Text] [Related]
3. Membrane raft lipid constituents affect drug susceptibilities of Candida albicans.
Pasrija R; Prasad T; Prasad R
Biochem Soc Trans; 2005 Nov; 33(Pt 5):1219-23. PubMed ID: 16246085
[TBL] [Abstract][Full Text] [Related]
4. Drug susceptibilities of yeast cells are affected by membrane lipid composition.
Mukhopadhyay K; Kohli A; Prasad R
Antimicrob Agents Chemother; 2002 Dec; 46(12):3695-705. PubMed ID: 12435664
[TBL] [Abstract][Full Text] [Related]
5. The Role of Ergosterol and Sphingolipids in the Localization and Activity of
Urbanek AK; Muraszko J; Derkacz D; Łukaszewicz M; Bernat P; Krasowska A
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077373
[TBL] [Abstract][Full Text] [Related]
6. Regulated overexpression of CDR1 in Candida albicans confers multidrug resistance.
Niimi M; Niimi K; Takano Y; Holmes AR; Fischer FJ; Uehara Y; Cannon RD
J Antimicrob Chemother; 2004 Dec; 54(6):999-1006. PubMed ID: 15486081
[TBL] [Abstract][Full Text] [Related]
7. TOP2 gene disruption reduces drug susceptibility by increasing intracellular ergosterol biosynthesis in Candida albicans.
Zheng H; Jiang YY; Wang Y; Jia XM; Yan TH; Gao PH; Yan L; Jiang LH; Ji H; Cao YB
J Med Microbiol; 2010 Jul; 59(Pt 7):797-803. PubMed ID: 20223895
[TBL] [Abstract][Full Text] [Related]
8. Multidrug transporters CaCdr1p and CaMdr1p of Candida albicans display different lipid specificities: both ergosterol and sphingolipids are essential for targeting of CaCdr1p to membrane rafts.
Pasrija R; Panwar SL; Prasad R
Antimicrob Agents Chemother; 2008 Feb; 52(2):694-704. PubMed ID: 18056285
[TBL] [Abstract][Full Text] [Related]
9. Substitution of threonine-1351 in the multidrug transporter Cdr1p of Candida albicans results in hypersusceptibility to antifungal agents and threonine-1351 is essential for synergic effects of calcineurin inhibitor FK520.
Shukla S; Ambudkar SV; Prasad R
J Antimicrob Chemother; 2004 Jul; 54(1):38-45. PubMed ID: 15190023
[TBL] [Abstract][Full Text] [Related]
10. Unexpected link between iron and drug resistance of Candida spp.: iron depletion enhances membrane fluidity and drug diffusion, leading to drug-susceptible cells.
Prasad T; Chandra A; Mukhopadhyay CK; Prasad R
Antimicrob Agents Chemother; 2006 Nov; 50(11):3597-606. PubMed ID: 16954314
[TBL] [Abstract][Full Text] [Related]
11. Morphogenic regulator EFG1 affects the drug susceptibilities of pathogenic Candida albicans.
Prasad T; Hameed S; Manoharlal R; Biswas S; Mukhopadhyay CK; Goswami SK; Prasad R
FEMS Yeast Res; 2010 Aug; 10(5):587-96. PubMed ID: 20491944
[TBL] [Abstract][Full Text] [Related]
12. Mitochondria influence CDR1 efflux pump activity, Hog1-mediated oxidative stress pathway, iron homeostasis, and ergosterol levels in Candida albicans.
Thomas E; Roman E; Claypool S; Manzoor N; Pla J; Panwar SL
Antimicrob Agents Chemother; 2013 Nov; 57(11):5580-99. PubMed ID: 23979757
[TBL] [Abstract][Full Text] [Related]
13. Synergistic activity of magnolol with azoles and its possible antifungal mechanism against Candida albicans.
Sun LM; Liao K; Liang S; Yu PH; Wang DY
J Appl Microbiol; 2015 Apr; 118(4):826-38. PubMed ID: 25641229
[TBL] [Abstract][Full Text] [Related]
14. Lactate Like Fluconazole Reduces Ergosterol Content in the Plasma Membrane and Synergistically Kills
Suchodolski J; Muraszko J; Bernat P; Krasowska A
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069257
[No Abstract] [Full Text] [Related]
15. Squalene epoxidase encoded by ERG1 affects morphogenesis and drug susceptibilities of Candida albicans.
Pasrija R; Krishnamurthy S; Prasad T; Ernst JF; Prasad R
J Antimicrob Chemother; 2005 Jun; 55(6):905-13. PubMed ID: 15845783
[TBL] [Abstract][Full Text] [Related]
16. Requirement for Ergosterol in Berberine Tolerance Underlies Synergism of Fluconazole and Berberine against Fluconazole-Resistant
Xu Y; Quan H; Wang Y; Zhong H; Sun J; Xu J; Jia N; Jiang Y
Front Cell Infect Microbiol; 2017; 7():491. PubMed ID: 29238700
[No Abstract] [Full Text] [Related]
17. Histone deacetylase inhibitors enhance Candida albicans sensitivity to azoles and related antifungals: correlation with reduction in CDR and ERG upregulation.
Smith WL; Edlind TD
Antimicrob Agents Chemother; 2002 Nov; 46(11):3532-9. PubMed ID: 12384361
[TBL] [Abstract][Full Text] [Related]
18. Membrane fluidity affects functions of Cdr1p, a multidrug ABC transporter of Candida albicans.
Smriti ; Krishnamurthy SS; Prasad R
FEMS Microbiol Lett; 1999 Apr; 173(2):475-81. PubMed ID: 10227177
[TBL] [Abstract][Full Text] [Related]
19. Ergosterol biosynthesis inhibitors become fungicidal when combined with calcineurin inhibitors against Candida albicans, Candida glabrata, and Candida krusei.
Onyewu C; Blankenship JR; Del Poeta M; Heitman J
Antimicrob Agents Chemother; 2003 Mar; 47(3):956-64. PubMed ID: 12604527
[TBL] [Abstract][Full Text] [Related]
20. Functional expression of Candida albicans drug efflux pump Cdr1p in a Saccharomyces cerevisiae strain deficient in membrane transporters.
Nakamura K; Niimi M; Niimi K; Holmes AR; Yates JE; Decottignies A; Monk BC; Goffeau A; Cannon RD
Antimicrob Agents Chemother; 2001 Dec; 45(12):3366-74. PubMed ID: 11709310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
